Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about the study conductors.SummaryDifference2%
- Check53 days agoChange DetectedSeveral key URLs related to genetics, diagnostic imaging, and clinical trials have been removed, indicating a significant reduction in available resources on these topics.SummaryDifference3%
- Check60 days agoChange DetectedNew resources have been added, including links to MedlinePlus for genetics and lung cancer, as well as information on diagnostic imaging and medications like Ferumoxytol and Pembrolizumab.SummaryDifference0.4%
- Check68 days agoChange DetectedThe website has been updated to include new features for downloading study data in various formats and has upgraded to revision v2.12.2, while removing the option to show less information and the previous revision v2.12.1.SummaryDifference3%
Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.